update on eloquent-2: phase 3 trial of elotuzumab in relapsed/refractory multiple myeloma
Published 8 years ago • 51 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
1:59
3-year update on the eloquent-2 clinical trial of elotuzumab in multiple myeloma
-
2:04
eloquent-2 trial: elotuzumab for relapsed or refractory multiple myeloma
-
1:41
eloquent-2 trial of elotuzumab plus lenalidomide/dexamethasone in multiple myeloma
-
2:00
results of eloquent-2 trial for treatment multiple myeloma
-
1:26
elotuzumab for the treatment of multiple myeloma
-
2:33
an update on antibody-based treatment approaches in multiple myeloma
-
1:09
an update on alliance a061202: addition of ixazomib to pomalidomide-dexamethasone in r/r myeloma
-
1:39
results of the phase 3 eloquent-2 trial
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
13:31
progress report ii - éva mlinkó
-
7:48
glofitamab, a cd20/cd3 bispecific antibody, in the treatment of r/r dlbcl
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
2:02
alnuctamab, a bcma x cd3 tce, in the treatment of multiple myeloma
-
2:21
overview of the tourmaline-mm1 study in relapsed/refractory multiple myeloma
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
3:45
update on phase i trial of teclistamab in r/r myeloma
-
1:56
randomized trials of pomalidomide combinations for mm
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
2:32
updates on the use of melflufen in r/r multiple myeloma
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
5:03
multiple myeloma clinical trials: what’s hot at ash 2015?
-
2:25
multiple myeloma at ash 2015: new therapeutic opportunities